<p>Sei Investments Co. 在第二季度将其在 Icon Plc (NASDAQ:ICLR - 免费报告) 的持股比例提高了 104.4%，根据该公司最近向证券交易委员会的披露。该公司在此期间购买了额外的 309,635 股后，持有 606,227 股这家医疗研究公司的股票。根据其最近向证券交易委员会的备案，Sei Investments Co. 拥有约 0.75% 的 Icon，价值 88,176,000 美元。</p>
<ul>
<li>3 家具有长期顺风的医疗保健先锋</li>
</ul>
<p>其他大型投资者也增加或减少了对该公司的持股。Artisan Partners Limited Partnership 在第二季度将其在 Icon 的持股提高了 67.4%。Artisan Partners Limited Partnership 目前拥有 7,184,870 股这家医疗研究公司的股票，价值 1,045,039,000 美元，此前在上个季度又收购了 2,893,946 股。挪威银行在第二季度新购入了价值 158,639,000 美元的 Icon 股票。1832 Asset Management L.P. 在第二季度将其在 Icon 的持股增加了 587.9%。1832 Asset Management L.P. 目前拥有 1,151,328 股这家医疗研究公司的股票，价值 167,461,000 美元，此前在此期间又购买了 983,950 股。马萨诸塞金融服务公司在第二季度将其在 Icon 的持股提高了 21.0%。马萨诸塞金融服务公司目前拥有 3,752,008 股这家医疗研究公司的股票，价值 545,730,000 美元，此前在上个季度又购买了 650,379 股。最后，Equity Investment Corp 在第二季度新购入了价值约 82,264,000 美元的 Icon 股票。机构投资者和对冲基金持有该公司 95.61% 的股票。</p>
<h2>华尔街分析师观点</h2>
<p>ICLR 已成为多份分析师报告的主题。Rothschild Redb 在 9 月 3 日的研究报告中将 Icon 的股票评级从 “持有” 上调至 “强烈买入”。Robert W. Baird 在 10 月 24 日的研究报告中对 Icon 的股票设定了 220.00 美元的目标价。Zacks Research 在 11 月 25 日的研究报告中将 Icon 的股票评级从 “强烈卖出” 上调至 “持有”。Weiss Ratings 在 12 月 1 日的报告中重申了对 Icon 股票的 “持有 (c-)” 评级。最后，Rothschild &amp; Co Redburn 在 9 月 3 日的报告中将 Icon 的评级从 “中性” 上调至 “买入”，并将其股票目标价从 184.00 美元提高至 236.00 美元。两位分析师对该股票给予了强烈买入评级，八位分析师给予了买入评级，十位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 205.00 美元。</p>
<ul>
<li>你应该把爱尔兰的好运带到你的投资中吗？</li>
</ul>
<p><strong>阅读我们关于 ICLR 的最新研究报告</strong></p>
<h2>Icon 股票表现</h2>
<p>NASDAQ ICLR 周五开盘价为 189.93 美元。该公司的 50 日移动平均价格为 176.65 美元，200 日移动平均价格为 166.03 美元。该股票的市值为 153.4 亿美元，市盈率为 25.70，市盈增长比率为 3.40，贝塔系数为 1.25。该公司的债务与股本比率为 0.31，速动比率为 1.06，流动比率为 1.06。Icon Plc 的 52 周低点为 125.10 美元，52 周高点为 228.29 美元。</p>
<h2>Icon 公司简介</h2>
<p>(免费报告)</p>
<p>ICON 公共有限公司是一家临床研究组织，提供在爱尔兰、欧洲其他地区、美国及国际上的外包开发和商业化服务。该公司专注于支持临床开发过程各个阶段的项目的战略开发、管理和分析，从化合物选择到 I-IV 期临床研究。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票比 Icon 更好</li>
<li>如何选择顶级评级股票</li>
<li>2026 年应避免的 3 只最近被下调的股票</li>
<li>如何投资蓝筹股</li>
<li>芯片热潮回归：3 只有巨大收益潜力的股票</li>
<li>3 只小盘股具有高回报潜力</li>
<li>甲骨文股票遭重创：为何其 AI 管道可能推动 2026 年的反弹</li>
</ul>
<p><strong>想看看其他对冲基金持有什么 ICLR 吗？</strong> 访问 HoldingsChannel.com 获取 Icon Plc (NASDAQ:ICLR - 免费报告) 的最新 13F 备案和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Icon 吗？</h2>
<p>在你考虑 Icon 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Icon 并不在名单上。</p>
<p>虽然 Icon 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

ICLR

<p>Sei Investments Co. 在第二季度将其在 Icon Plc 的股份增加了 104.4%，目前持有 606,227 股，价值 8,818 万美元。其他主要投资者也增加了他们的持股。Icon 的股票共识评级为 “适度买入”，目标价格为 205.00 美元。该股票在周五以 189.93 美元开盘，市值为 153.4 亿美元</p>

<p>Sei Investments Co. lifted its stake in Icon Plc (NASDAQ:ICLR - Free Report) by 104.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 606,227 shares of the medical research company's stock after buying an additional 309,635 shares during the period. Sei Investments Co. owned approximately 0.75% of Icon worth $88,176,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>Sei Investments Co. 在第二季度将其在 Icon Plc (NASDAQ:ICLR - 免费报告) 的持股比例提高了 104.4%，根据该公司最近向证券交易委员会的披露。该公司在此期间购买了额外的 309,635 股后，持有 606,227 股这家医疗研究公司的股票。根据其最近向证券交易委员会的备案，Sei Investments Co. 拥有约 0.75% 的 Icon，价值 88,176,000 美元。</p>
</div><ul>
<li>3 Healthcare Pathbreakers With Long-Term Tailwinds</li>
</ul>
<div class="lb-trans"><ul>
<li>3 家具有长期顺风的医疗保健先锋</li>
</ul>
</div><p>Other large investors have also added to or reduced their stakes in the company. Artisan Partners Limited Partnership raised its holdings in Icon by 67.4% in the 2nd quarter. Artisan Partners Limited Partnership now owns 7,184,870 shares of the medical research company's stock valued at $1,045,039,000 after acquiring an additional 2,893,946 shares in the last quarter. Norges Bank acquired a new stake in shares of Icon during the 2nd quarter worth $158,639,000. 1832 Asset Management L.P. increased its position in shares of Icon by 587.9% in the second quarter. 1832 Asset Management L.P. now owns 1,151,328 shares of the medical research company's stock worth $167,461,000 after purchasing an additional 983,950 shares during the period. Massachusetts Financial Services Co. MA raised its stake in Icon by 21.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,752,008 shares of the medical research company's stock valued at $545,730,000 after purchasing an additional 650,379 shares in the last quarter. Finally, Equity Investment Corp bought a new stake in Icon during the second quarter worth about $82,264,000. Institutional investors and hedge funds own 95.61% of the company's stock.</p>
<div class="lb-trans"><p>其他大型投资者也增加或减少了对该公司的持股。Artisan Partners Limited Partnership 在第二季度将其在 Icon 的持股提高了 67.4%。Artisan Partners Limited Partnership 目前拥有 7,184,870 股这家医疗研究公司的股票，价值 1,045,039,000 美元，此前在上个季度又收购了 2,893,946 股。挪威银行在第二季度新购入了价值 158,639,000 美元的 Icon 股票。1832 Asset Management L.P. 在第二季度将其在 Icon 的持股增加了 587.9%。1832 Asset Management L.P. 目前拥有 1,151,328 股这家医疗研究公司的股票，价值 167,461,000 美元，此前在此期间又购买了 983,950 股。马萨诸塞金融服务公司在第二季度将其在 Icon 的持股提高了 21.0%。马萨诸塞金融服务公司目前拥有 3,752,008 股这家医疗研究公司的股票，价值 545,730,000 美元，此前在上个季度又购买了 650,379 股。最后，Equity Investment Corp 在第二季度新购入了价值约 82,264,000 美元的 Icon 股票。机构投资者和对冲基金持有该公司 95.61% 的股票。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>ICLR has been the subject of several analyst reports. Rothschild Redb upgraded shares of Icon from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Wednesday, September 3rd. Robert W. Baird set a $220.00 price objective on shares of Icon in a research note on Friday, October 24th. Zacks Research upgraded shares of Icon from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, November 25th. Weiss Ratings reaffirmed a &#34;hold (c-)&#34; rating on shares of Icon in a report on Monday, December 1st. Finally, Rothschild &amp; Co Redburn raised Icon from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and boosted their price target for the stock from $184.00 to $236.00 in a report on Wednesday, September 3rd. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and ten have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $205.00.</p>
<div class="lb-trans"><p>ICLR 已成为多份分析师报告的主题。Rothschild Redb 在 9 月 3 日的研究报告中将 Icon 的股票评级从 “持有” 上调至 “强烈买入”。Robert W. Baird 在 10 月 24 日的研究报告中对 Icon 的股票设定了 220.00 美元的目标价。Zacks Research 在 11 月 25 日的研究报告中将 Icon 的股票评级从 “强烈卖出” 上调至 “持有”。Weiss Ratings 在 12 月 1 日的报告中重申了对 Icon 股票的 “持有 (c-)” 评级。最后，Rothschild &amp; Co Redburn 在 9 月 3 日的报告中将 Icon 的评级从 “中性” 上调至 “买入”，并将其股票目标价从 184.00 美元提高至 236.00 美元。两位分析师对该股票给予了强烈买入评级，八位分析师给予了买入评级，十位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 205.00 美元。</p>
</div><ul>
<li>Should You Bring The Luck Of The Irish To Your Investmets?</li>
</ul>
<div class="lb-trans"><ul>
<li>你应该把爱尔兰的好运带到你的投资中吗？</li>
</ul>
</div><p><strong>Read Our Latest Research Report on ICLR</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 ICLR 的最新研究报告</strong></p>
</div><h2>Icon Stock Performance</h2>
<div class="lb-trans"><h2>Icon 股票表现</h2>
</div><p>NASDAQ ICLR opened at $189.93 on Friday. The firm's fifty day moving average price is $176.65 and its two-hundred day moving average price is $166.03. The stock has a market cap of $15.34 billion, a PE ratio of 25.70, a PEG ratio of 3.40 and a beta of 1.25. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.06 and a current ratio of 1.06. Icon Plc has a fifty-two week low of $125.10 and a fifty-two week high of $228.29.</p>
<div class="lb-trans"><p>NASDAQ ICLR 周五开盘价为 189.93 美元。该公司的 50 日移动平均价格为 176.65 美元，200 日移动平均价格为 166.03 美元。该股票的市值为 153.4 亿美元，市盈率为 25.70，市盈增长比率为 3.40，贝塔系数为 1.25。该公司的债务与股本比率为 0.31，速动比率为 1.06，流动比率为 1.06。Icon Plc 的 52 周低点为 125.10 美元，52 周高点为 228.29 美元。</p>
</div><h2>Icon Profile</h2>
<div class="lb-trans"><h2>Icon 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.</p>
<div class="lb-trans"><p>ICON 公共有限公司是一家临床研究组织，提供在爱尔兰、欧洲其他地区、美国及国际上的外包开发和商业化服务。该公司专注于支持临床开发过程各个阶段的项目的战略开发、管理和分析，从化合物选择到 I-IV 期临床研究。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Icon</li>
<li>How to Choose Top Rated Stocks</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li>
<li>3 Small Caps With Big Return Potential</li>
<li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Icon 更好</li>
<li>如何选择顶级评级股票</li>
<li>2026 年应避免的 3 只最近被下调的股票</li>
<li>如何投资蓝筹股</li>
<li>芯片热潮回归：3 只有巨大收益潜力的股票</li>
<li>3 只小盘股具有高回报潜力</li>
<li>甲骨文股票遭重创：为何其 AI 管道可能推动 2026 年的反弹</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ICLR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有什么 ICLR 吗？</strong> 访问 HoldingsChannel.com 获取 Icon Plc (NASDAQ:ICLR - 免费报告) 的最新 13F 备案和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ICLR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Icon Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Icon 吗？</h2>
</div><p>Before you consider Icon, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Icon 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Icon wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Icon 并不在名单上。</p>
</div><p>While Icon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Icon 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Sei Investments Co. 收购了 Icon Plc 的 309,635 股股份，股票代码为 $ICLR